ELI LILLY H9B-MC-BCDS

By June 19, 2019 Closed

“A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE)”

Leave a Reply